California to begin selling affordable, state-branded insulin beginning next year
Read Original Source
Gov. Gavin Newsom said Thursday that California will begin selling affordable insulin under its own label on Jan. 1, nearly three years after he first announced a partnership to sell state-branded generic drugs at lower prices. Limited time: Save 25% on NBC News subscription Get exclusive reporting, live Q&As and ad-free reading. But California won’t be the only state making lower-cost insulin available. The nonprofit Civica said it will also distribute its economical diabetes medication to pharmacies nationwide.
AI Summary
Main Idea: California will start selling lower-cost state-branded insulin next year as part of Governor Gavin Newsom’s effort to cut prescription drug prices.
Key Points:
- The CalRx insulin pens will go on sale Jan. 1 at a recommended price of $11 each, or up to $55 for a five-pack.
- Newsom said people will not need a new prescription, and the goal is to improve access by making the drug more affordable.
- Civica, which partnered with California in 2023, said it will also distribute the lower-cost insulin nationwide.
- State officials hope the program will save patients thousands of dollars a year, though analysts have warned it could affect the wider drug market.
Impact on the People
Negative Impact
California’s entry into insulin sales could push other makers to cut supply, which may create shortages or less choice for patients.
Positive Impact
Lower-priced state-branded insulin from Newsom, Civica, and Biocon Biologics could save diabetes patients thousands of dollars a year and ease costs for families and public health plans.
How did each entity affect people?
Rate how each entity in this article affected the American people.
- Primary:Civicanonprofit / NGO
- Primary:Governor Gavin Newsomperson
Candidate Entities5 candidates · 5 weighted vote min · 70% decision
- Civicanonprofit / NGOPrimaryEvaluated
Key nonprofit partner in California’s insulin effort and the organization distributing lower-cost insulin nationwide.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Governor Gavin NewsompersonPrimaryEvaluated
Central public official announcing California’s plan to sell state-branded insulin and framing the affordability rationale.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Biocon BiologicscompanyMajorAI selected
Named manufacturing partner in the state insulin deal and part of the development and supply effort.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Eli Lilly and CompanycompanyContextCandidate
Named pharmaceutical competitor used for price comparison in the article.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Health Access Californianonprofit / NGOContextCandidate
Named consumer advocacy group reacting to the announcement and supporting the cost-lowering effort.
Include 0 (0%)Ignore 0 (0%)5 to threshold
Comments 0
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to comment